Heart failure & cardiomyopathies

Sex Disparities in Longitudinal Use and Intensification of Guideline-Directed Medical Therapy Among Patients With Newly Diagnosed Heart Failure With Reduced Ejection Fraction

CirculationPublished Retrospective cohort study

Main finding · Probability of achieving optimal GDMTResult — go to the resultHazard ratio 0.77 95% CI 0.71–0.83

Authors' conclusion

Overall use of optimal GDMT after HFrEF diagnosis was low, with significantly lower use among female (compared with male) patients.

Study context

Population
Patients with incident heart failure with reduced ejection fraction (HFrEF), US commercial and Medicare Advantage claims database (Optum Clinformatics), 2016–2020
Participants
63,759 patients
Exposure
Female vs male patients
Outcome
Use of optimal GDMT (≥50% target dose beta-blocker plus ≥50% target dose ACEi or ARB, or any dose ARNI, plus any dose MRA)
Follow-up
Within 12 months of HFrEF diagnosis
Methodological detailsadministrative claims database
  • Administrative claims database

Main finding

Probability of achieving optimal GDMT

Hazard ratio

0.77

95% CI 0.71–0.83

P < 0.001

Femalevs Male
HR 0.77 (95% CI 0.71–0.83); P < 0.001

As reported in the abstract

Optimal GDMT achieved at 12 months, all patients
6.2%

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)
Optimal GDMT, by insurance (subgroup)Femalevs MaleCommercial insurance0.66 (0.58–0.76)
Optimal GDMT, by insurance (subgroup)Femalevs MaleMedicare0.85 (0.77–0.92)
Optimal GDMT, by age (subgroup)Femalevs MaleAge <65 years0.65 (0.58–0.74)
Optimal GDMT, by age (subgroup)Femalevs MaleAge ≥65 years (as printed)87 (80–96)
  • Optimal GDMT, by insurance (subgroup): interaction P (sex × insurance status)=0.005
  • Optimal GDMT, by age (subgroup): interaction P (sex × age)=0.009

Original publication

Sex Disparities in Longitudinal Use and Intensification of Guideline-Directed Medical Therapy Among Patients With Newly Diagnosed Heart Failure With Reduced Ejection Fraction. Circulation. Published 23 January 2024. doi:10.1161/circulationaha.123.067489

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.